• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组分析在破解冠状病毒大流行中的重要性。

The importance of genomic analysis in cracking the coronavirus pandemic.

机构信息

Institute of Human Virology, Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, USA.

, Member of the Global Virus Network, Baltimore, USA.

出版信息

Expert Rev Mol Diagn. 2021 Jun;21(6):547-562. doi: 10.1080/14737159.2021.1917998. Epub 2021 Apr 28.

DOI:10.1080/14737159.2021.1917998
PMID:33849359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8095159/
Abstract

: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has pushed the scientific community to undertake intense research efforts. Understanding SARS-CoV-2 biology is necessary to discover therapeutic or preventive strategies capable of containing the pandemic. Knowledge of the structural characteristics of the virus genome and proteins is essential to find targets for therapies and immunological interventions.: This review covers different areas of expertise, genomic analysis of circulating strains, structural biology, viral mutations, molecular diagnostics, disease, and vaccines. In particular, the review is focused on the molecular approaches and modern clinical strategies used in these fields.: Molecular approaches to SARS-CoV-2 pandemic have been critical to shorten time for new diagnostic, therapeutic and prevention strategies. In this perspective, the entire scientific community is moving in the same direction. Vaccines, together with the development of new drugs to treat the disease, represent the most important strategy to protect human from viral disease and prevent further spread. In this regard, new molecular technologies have been successfully implemented. The use of a novel strategy of communication is suggested for a better diffusion to the broader public of new data and results.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行促使科学界进行了密集的研究工作。了解 SARS-CoV-2 的生物学特性对于发现能够控制大流行的治疗或预防策略是必要的。了解病毒基因组和蛋白质的结构特征对于寻找治疗和免疫干预的靶点至关重要。

本综述涵盖了不同的专业领域,包括循环株的基因组分析、结构生物学、病毒突变、分子诊断、疾病和疫苗。特别是,该综述重点介绍了这些领域中使用的分子方法和现代临床策略。

分子方法在 SARS-CoV-2 大流行中至关重要,可以缩短新的诊断、治疗和预防策略的时间。在这方面,整个科学界都在朝着同一个方向前进。疫苗以及开发治疗这种疾病的新药是保护人类免受病毒疾病侵害并防止进一步传播的最重要策略。在这方面,已经成功实施了新的分子技术。建议采用新的沟通策略,以便更广泛地向公众传播新的数据和结果。

相似文献

1
The importance of genomic analysis in cracking the coronavirus pandemic.基因组分析在破解冠状病毒大流行中的重要性。
Expert Rev Mol Diagn. 2021 Jun;21(6):547-562. doi: 10.1080/14737159.2021.1917998. Epub 2021 Apr 28.
2
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.SARS-CoV-2 感染:新的分子、系统发生和发病机制见解。当前疫苗的功效和变异的潜在风险。
Viruses. 2021 Aug 25;13(9):1687. doi: 10.3390/v13091687.
3
Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.SARS-CoV-2 的遗传学和基因组学:文献综述,特别关注遗传多样性和 SARS-CoV-2 基因组检测。
Genomics. 2021 Jan;113(1 Pt 2):1221-1232. doi: 10.1016/j.ygeno.2020.09.059. Epub 2020 Sep 30.
4
The variants question: What is the problem?变体问题:问题是什么?
J Med Virol. 2021 Dec;93(12):6479-6485. doi: 10.1002/jmv.27196. Epub 2021 Jul 28.
5
Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia.哥伦比亚大流行第一年样本中 SARS-CoV-2 基因组的突变特征。
Infect Genet Evol. 2022 Jan;97:105192. doi: 10.1016/j.meegid.2021.105192. Epub 2021 Dec 18.
6
Emergence of novel SARS-CoV-2 variants in the Netherlands.荷兰出现新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种。
Sci Rep. 2021 Mar 23;11(1):6625. doi: 10.1038/s41598-021-85363-7.
7
A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.一种无缺口、无歧义的 SARS-CoV-2 变体的 RNA 宏基因组组装基因组序列,该变体编码 Spike S813I 和 ORF1a A859V 取代。
OMICS. 2021 Feb;25(2):123-128. doi: 10.1089/omi.2020.0194. Epub 2020 Nov 30.
8
Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID-19?紧急出现的 SARS-CoV2 B.1.1.7 谱系是否会影响 COVID-19 的分子诊断?
J Med Virol. 2021 May;93(5):2566-2568. doi: 10.1002/jmv.26823. Epub 2021 Feb 9.
9
SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview.SARS-CoV-2 谱系及其在全球传播的亚谱系:动态概述。
Chemotherapy. 2021;66(1-2):3-7. doi: 10.1159/000515340. Epub 2021 Mar 18.
10
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.SARS-CoV-2 变体和 COVID-19 疫苗:当前的挑战与未来策略。
Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28.

引用本文的文献

1
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI.呼吸系统疾病的疫苗接种策略:来自AIPO-ITS/ETS、SIMIT、SIP/IRS和SItI的建议。
Respiration. 2025;104(8):556-574. doi: 10.1159/000544919. Epub 2025 Mar 9.
2
Effect of COVID-19 vaccine in adults infected with the Delta variant of SARS-CoV-2: a retrospective cohort study.新冠病毒 2019 年病疫苗对感染严重急性呼吸综合征冠状病毒 2 型德尔塔变异株的成年人的影响:一项回顾性队列研究。
J Thorac Dis. 2024 Oct 31;16(10):6983-6998. doi: 10.21037/jtd-24-1351. Epub 2024 Oct 15.
3
Anticoagulant therapy in adult with COVID-19: a systematic review and meta-analysis of randomized controlled trial.成人 COVID-19 患者的抗凝治疗:一项随机对照试验的系统评价和荟萃分析
J Thorac Dis. 2024 Oct 31;16(10):6391-6405. doi: 10.21037/jtd-24-744. Epub 2024 Oct 17.
4
Effects of Contagious Respiratory Pathogens on Breath Biomarkers.传染性呼吸道病原体对呼吸生物标志物的影响。
Antioxidants (Basel). 2024 Jan 29;13(2):172. doi: 10.3390/antiox13020172.
5
A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over.一种新型的 COVID-19 变体,Eris,可能是 2023 年需要关注的对象,亦或尚未结束。
Infect Disord Drug Targets. 2024;24(6):e220124225916. doi: 10.2174/0118715265276833240105110046.
6
Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants.经染色体工程改造的源自牛的抗SARS-CoV-2多克隆人抗体可保护hACE2转基因仓鼠免受多种变体的侵害。
iScience. 2023 Aug 29;26(10):107764. doi: 10.1016/j.isci.2023.107764. eCollection 2023 Oct 20.
7
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients.新冠病毒肺炎患者白细胞DNA损伤的临床研究
Curr Issues Mol Biol. 2023 Jan 19;45(2):963-974. doi: 10.3390/cimb45020062.
8
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients.口腔细菌疗法可降低新冠病毒感染患者慢性疲劳的发生率。
Front Nutr. 2022 Jan 12;8:756177. doi: 10.3389/fnut.2021.756177. eCollection 2021.
9
A Multiallelic Molecular Beacon-Based Real-Time RT-PCR Assay for the Detection of SARS-CoV-2.一种基于多等位基因分子信标的实时逆转录聚合酶链反应检测法用于检测严重急性呼吸综合征冠状病毒2
Life (Basel). 2021 Oct 27;11(11):1146. doi: 10.3390/life11111146.
10
Shared Mutations in Emerging SARS-CoV-2 Circulating Variants May Lead to Reverse Transcription-PCR (RT-PCR)-Based Misidentification of B.1.351 and P.1 Variants of Concern.新兴 SARS-CoV-2 循环变异株中的共享突变可能导致基于逆转录聚合酶链反应(RT-PCR)的 B.1.351 和 P.1 关注变异株的错误鉴定。
Microbiol Spectr. 2021 Oct 31;9(2):e0081621. doi: 10.1128/Spectrum.00816-21. Epub 2021 Oct 13.

本文引用的文献

1
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch.利用“圣诞怪杰”追踪严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系B.1.1.7和B.1.351/501Y-V2的国际传播情况
Wellcome Open Res. 2021 Sep 17;6:121. doi: 10.12688/wellcomeopenres.16661.2. eCollection 2021.
2
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.多重实时荧光定量 PCR 可区分关注变异株,增强全球对 SARS-CoV-2 的监测。
PLoS Biol. 2021 May 7;19(5):e3001236. doi: 10.1371/journal.pbio.3001236. eCollection 2021 May.
3
SARS-CoV-2 Infection and the COVID-19 Pandemic Emergency: The Importance of Diagnostic Methods.严重急性呼吸综合征冠状病毒2感染与2019冠状病毒病大流行紧急情况:诊断方法的重要性
Chemotherapy. 2021;66(1-2):17-23. doi: 10.1159/000515343. Epub 2021 Mar 19.
4
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.mRNA-1273疫苗引发的血清中和活性。
N Engl J Med. 2021 Apr 15;384(15):1468-1470. doi: 10.1056/NEJMc2102179. Epub 2021 Mar 17.
5
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.科维希尔德腺病毒载体新冠疫苗(ChAdOx1 nCoV-19)对 B.1.351 变异株的有效性。
N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16.
6
Detection of a SARS-CoV-2 variant of concern in South Africa.南非出现一种令人关注的 SARS-CoV-2 变异株。
Nature. 2021 Apr;592(7854):438-443. doi: 10.1038/s41586-021-03402-9. Epub 2021 Mar 9.
7
Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.缺失的谜团:SARS-CoV-2 的神秘 ORF8 蛋白。
Biochem Biophys Res Commun. 2021 Jan 29;538:116-124. doi: 10.1016/j.bbrc.2020.10.045. Epub 2020 Oct 21.
8
Neutralizing Activity of BNT162b2-Elicited Serum.BNT162b2诱导血清的中和活性
N Engl J Med. 2021 Apr 15;384(15):1466-1468. doi: 10.1056/NEJMc2102017. Epub 2021 Mar 8.
9
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.基因组证据表明巴西出现涉及 Spike 蛋白 E484K 突变的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
10
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.BNT162b2 疫苗诱导的人血清对 SARS-CoV-2 谱系 B.1.1.7 假病毒的中和作用。
Science. 2021 Mar 12;371(6534):1152-1153. doi: 10.1126/science.abg6105. Epub 2021 Jan 29.